Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
Ibrance
ibritumomab tiuxetan regimen
ibrutinib Leukemia Multiple Myeloma Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Waldenström's Macroglobulinemia Ibrutinib Lymphoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
Iclusig
idarubicin Idarubicin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Leukemia Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
idecabtagene vicleucel Multiple Myeloma Idecabtagene vicleucel Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
ide-cel
idelalisib
Idhifa
Ifex
IFN
ifosfamide Bladder Cancer Endometrial Cancer Ifosfamide Osteogenic Sarcoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Cervical Cancer Head and Neck Cancer Lymphoma Soft Tissue Sarcomas Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Testicular Cancer
IL-2 Aldesleukin Renal Cell Cancer
imatinib Gastrointestinal Stromal Tumor (GIST) Leukemia Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Imatinib Myelodysplastic Syndrome Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
IMC-1121B
IMC-C225
Imfinzi
Imjudo
IMMU-132
ibritumomab
ICE
Idamycin
IDEC-Y2B8
idelasib
IDR
IFL saltz regimen
IFN-
Imbruvica
IMC-11F8
IMC-gp100